VANCOUVER, BRITISH COLUMBIA–(Marketwired – June 23, 2017) – Reliq Health Technologies Inc. (TSX VENTURE:RHT)(OTCQB:RQHTF) (“Reliq” or the “Company“), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announced that further to its news release dated June 9, 2017 and June 22, 2017, the Company has received final TSX Venture Exchange approval on the non-brokered private placement of 6,937,200 Units (the “Units“) of the Company at a price of $0.11 per Unit for gross proceeds of $763,092.00.
Each Unit each consists of one (1) common share (the “Common Share“) and one half (1/2) transferrable share purchase warrant (the “Warrant“). Each of the 3,468,600 warrants entitles the holder thereof to purchase one (1) additional Common Share.
The subscribers to the private placement agreed to a voluntary 6 month hold period on securities issued.
Total Pro Group involvement for 4,546,200 Units in the amount of $500,000.00 was subscribed for by one individual.
ON BEHALF OF THE BOARD
Dr. Lisa Crossley, CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the “Company“) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
